Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
Clinical trial NCT04333420 · COMPLETED
Trial details
- NCT number
- NCT04333420
- Sponsor
- InflaRx GmbH
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2021-10-31
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.